sb 202190 has been researched along with Pneumococcal Infections in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Pneumococcal Infections: Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| N'Guessan, PD | 1 |
| Hippenstiel, S | 1 |
| Etouem, MO | 1 |
| Zahlten, J | 1 |
| Beermann, W | 1 |
| Lindner, D | 1 |
| Opitz, B | 1 |
| Witzenrath, M | 1 |
| Rosseau, S | 1 |
| Suttorp, N | 1 |
| Schmeck, B | 1 |
1 other study available for sb 202190 and Pneumococcal Infections
| Article | Year |
|---|---|
Streptococcus pneumoniae induced p38 MAPK- and NF-kappaB-dependent COX-2 expression in human lung epithelium.
Topics: Base Sequence; Cell Line; Cyclooxygenase 2; DNA Primers; Enzyme Induction; Enzyme Inhibitors; Gene E | 2006 |